Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Real-time ultrasound-guided infraorbital nerve block to treat trigeminal neuralgia using a high concentration of tetracaine dissolved in bupivacaine.

Authors:
Kenichi Takechi Amane Konishi Kotaro Kikuchi Shiho Fujioka Tomomi Fujii Toshihiro Yorozuya Koh Kuzume Takumi Nagaro

Scand J Pain 2015 Jan 1;6(1):51-54. Epub 2015 Jan 1.

Ehime University Graduate School of Medicine, Department of Anesthesia and Perioperative Medicine, Ehime Japan.

Background Trigeminal neuralgia is a neuropathic disorder characterized by episodes of intense pain in the face. Drug therapy is the first choice of treatment. However, in cases where drug therapy are contraindicated due to side effects, patients can get pain relief from lengthy neurosurgical procedures. Alternatively, a peripheral trigeminal nerve block can be easily performed in an outpatient setting. Therefore it is a useful treatment option for the acute paroxysmal period of TN in patients who cannot use drug therapy. We performed real-time ultrasound guidance for infraorbital nerve blocks in TN patients using a high concentration of tetracaine dissolved in bupivacaine. In this report, we examine the efficacy of our methods. Patients As approved by the Institutional Review Board, the medical records in our hospital were queried retrospectively. Six patients with TN at the V2 area matched the study criteria. All patients could not continue drug therapy with carbamazepine due to side effects and they received an ultrasound-guided infraorbital nerve block with a high concentration of tetracaine dissolved in bupivacaine. Methods The patient was placed in the supine position and the patient's face was sterilized and draped. An ultrasound system with a 6-13 MHz linear probe was used with a sterile cover. The probe was inserted into the horizontal plane of the cheek just beside the nose and was slid in the cranial direction to find the dimple of the infraorbital foramen. The 25G 25 mm needle was inserted from the caudal side just across from the probe using an out-of-plane approach. To lead the needle tip to the foramen, needle direction was corrected with real-time ultrasound guidance. After the test block with lidocaine (2%, 0.5 ml), a solution of tetracaine (20 mg) dissolved in bupivacaine (0.5%, 0.5 ml) was injected. During each injection, the spread of the agent around the nerve was confirmed using ultrasound images. Results Ten blocks were performed for six patients. Immediately after the procedure, all 10 blocks produced analgesia and relieved the pain. In the three blocks, pain was experienced in a new trigger point outside of the infraorbital nerve region (around the back teeth) within a week after the block and pain were relieved using other treatment. Two patients developed small hematomas in the cheek but they disappeared in a week. All patients did not complain about other side effects including paraesthesia, hyperpathia, dysaesthesia, or double vision. Hypoaesthesia to touch and pain in the infraorbital region were observed in all blocks after 2 weeks. Conclusions We performed real-time ultrasound-guided infraorbital nerve block for TN with a high concentration of tetracaine dissolved in bupivacaine. Our method achieved a high success rate and there were only minor and transient side effects. Implications Real-time ultrasound-guided infraorbital nerve block is one of the useful options to treat the acute paroxysmal period of TN at the infraorbital nerve area. Ultrasound-guided injections may become the standard practice for injecting peripheral trigeminal nerves. Using this high concentration of tetracaine as a neurolytic agent is effective and appears to have only minor side effects.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sjpain.2014.10.003DOI Listing
January 2015

Publication Analysis

Top Keywords

infraorbital nerve
28
tetracaine dissolved
20
nerve block
20
side effects
20
concentration tetracaine
20
dissolved bupivacaine
20
high concentration
20
ultrasound-guided infraorbital
16
drug therapy
16
real-time ultrasound-guided
12
infraorbital
9
nerve
9
patients
9
performed real-time
8
ultrasound guidance
8
peripheral trigeminal
8
trigeminal neuralgia
8
block high
8
real-time ultrasound
8
acute paroxysmal
8

Keyword Occurance

Similar Publications

Pain Relief in a Trigeminal Neuralgia Model Optogenetic Inhibition on Trigeminal Ganglion Itself With Flexible Optic Fiber Cannula.

Authors:
Elina Kc Jaisan Islam Soochong Kim Hyong Kyu Kim Young Seok Park

Front Cell Neurosci 2022 28;16:880369. Epub 2022 Apr 28.

Department of Medical Neuroscience, College of Medicine, Chungbuk National University, Cheongju, South Korea.

The trigeminal ganglion (TG) is the primary site of aberration in trigeminal neuralgia (TN), and hence a crucial site where afferent input can be modulated. Here, we postulated that inhibiting TG optogenetics using flexible optic cannula would diminish brainstem trigeminal nucleus caudalis (TNC) neuronal activity and pain behavior in TN rat model. Infraorbital nerve constriction was employed to induce TN in female Sprague-Dawley rats, while naive and sham rats served as controls. Read More

View Article and Full-Text PDF
April 2022
Similar Publications

Cerebroventricular administration of anti-calcitonin gene-related peptide antibody reduces the increase of dopamine D2 receptor observed in the trigeminal spinal subnucleus caudalis following infraorbital nerve ligation.

Authors:
Hiroharu Maegawa Chiaki Yoshikawa Nayuka Usami Hitoshi Niwa

Biochem Biophys Res Commun 2022 May 10;614:78-84. Epub 2022 May 10.

Department of Dental Anesthesiology, Osaka University Graduate School of Dentistry, Suita, Osaka, 565-0871, Japan. Electronic address:

A dopamine D2 receptor (D2R) agonist and an anti-calcitonin gene-related peptide (CGRP) antibody were separately reported to reduce neuropathic pain. To further attenuate neuropathic pain, co-administration of a D2R agonist and an anti-CGRP antibody was performed in a rat with the infraorbital nerve (ION) ligation. However, this co-administration showed no further attenuation of mechanical hypersensitivity compared to the administration of anti-CGRP antibody alone. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Cardiopulmonary Effects and Pharmacokinetics of Dexmedetomidine Used as an Adjunctive Analgesic to Regional Anesthesia of the Oral Cavity with Levobupivacaine in Dogs.

Authors:
Matic Pavlica Mojca Kržan Ana Nemec Tina Kosjek Anže Baš Alenka Seliškar

Animals (Basel) 2022 May 9;12(9). Epub 2022 May 9.

Small Animal Clinic, Veterinary Faculty, University of Ljubljana, 1000 Ljubljana, Slovenia.

This study investigated the cardiopulmonary effects and pharmacokinetics of dexmedetomidine (DEX) used as an adjunctive analgesic for regional anesthesia of the oral cavity with levobupivacaine in anesthetized dogs. Forty dogs were randomly assigned to four groups of 10 dogs. All dogs received levobupivacaine (4 blocks) with DEX IO (infraorbital block, = 10) or IA (inferior alveolar block, = 10) or placebo (PLC; = 10) or DEX ( = 10) was injected intravenously (IV) after administration of levobupivacaine. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

Localization of The Infraorbital Foramen with Reference to Facial Bony Landmarks: The Predictive Method And Its Accuracy.

Authors:
Jiraporn Suntiruamjairucksa Vilai Chentanez

FASEB J 2022 May;36 Suppl 1

Department of Anatomy, Faculty of Medicine, Chulalongkorn University, Bangkok.

The infraorbital nerve (ION) provides sensation around mid-face and the ION block is used for regional anesthesia in many procedures. Therefore, the location of infraorbital foramen (IOF) and accessory infraorbital foramen (AIOF) where the ION and its branches exit through is important. Although, many studies tried to identify the location of the foramen using facial landmarks, the results varied and some of them were not applicable in practice. Read More

View Article and Full-Text PDF
May 2022
Similar Publications

ACR Appropriateness Criteria® Imaging of Facial Trauma Following Primary Survey.

Authors:
Matthew S Parsons Bruno Policeni Amy F Juliano Mohit Agarwal Elizabeth R Benjamin Judah Burns Timothy Doerr Prachi Dubey Elliott R Friedman Maria K Gule-Monroe Karol A Gutowski Mari Hagiwara Vikas Jain Tanya J Rath Brian Shian Devaki Shilpa Surasi M Reza Taheri David Zander Amanda S Corey

J Am Coll Radiol 2022 May;19(5S):S67-S86

Specialty Chair, Atlanta VA Health Care System and Emory University, Atlanta, Georgia.

Maxillofacial trauma patients comprise a significant subset of patients presenting to emergency departments. Before evaluating for facial trauma, an emergency or trauma physician must perform a primary survey to ensure patient stabilization. Following this primary survey, this document discusses the following clinical scenarios for facial trauma: tenderness to palpation or contusion or edema over frontal bone (suspected frontal bone injury); pain with upper jaw manipulation or pain overlying zygoma or zygomatic deformity or facial elongation or malocclusion or infraorbital nerve paresthesia (suspected midface injury); visible nasal deformity or palpable nasal deformity or tenderness to palpation of the nose or epistaxis (suspected nasal bone injury); and trismus or malocclusion or gingival hemorrhage or mucosal hemorrhage or loose teeth or fractured teeth or displaced teeth (suspected mandibular injury). Read More

View Article and Full-Text PDF
May 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap